Sugi Predict

Sugi Predict / Compounds / SCHEMBL19784878

SCHEMBL19784878

SCHEMBL19784878

c1ccc(N(c2ccccc2)c2ccc3sc4c(c3c2)c2ccccc2c2[nH]c3ccccc3c24)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.47
▸ KMT2A Q03164 5/20 0.47
▸ MAPT P10636 4/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ HTT P42858 2/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ TNKS O95271 1/20 0.43
▸ TNKS2 Q9H2K2 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ PPARG P37231 1/20 0.43
▸ NCOA2 Q15596 1/20 0.43
▸ NCOA1 Q15788 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ NCOA3 Q9Y6Q9 1/20 0.43
▸ CDK4 P11802 4/20 0.40
▸ CCND1 P24385 4/20 0.40
▸ MAP3K9 P80192 3/20 0.40
▸ MAP3K11 Q16584 3/20 0.40
▸ GABRP O00591 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19660128 0.91 MEN1 (0.48) MEN1KMT2AMAPTRAB9AHTT
SCHEMBL14951573 0.83 CYP1A2 (0.35) MEN1KMT2AMAPTRAB9AHTT
SCHEMBL14951565 0.82 MEN1 (0.51) MEN1KMT2AMAPTRAB9AHTT
SCHEMBL14951582 0.82 MEN1 (0.51) MEN1KMT2AMAPTRAB9AHTT
SCHEMBL22012011 0.81 MEN1 (0.40) MEN1KMT2AMAPTRAB9AHTT
SCHEMBL15003544 0.80 MEN1 (0.67) MEN1KMT2AMAPTRAB9AHTT
SCHEMBL17658670 0.78 CYP1A2 (0.33) MEN1KMT2AMAPTRAB9AHTT
SCHEMBL15003805 0.77 MEN1 (0.48) MEN1KMT2AMAPTRAB9AHTT
SCHEMBL14951584 0.77 KIF11 (0.54) MEN1KMT2AMAPTRAB9AHTT
SCHEMBL14951591 0.77 HTT (0.72) MEN1KMT2AMAPTRAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240141-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-27 — — US disclosed
WO-2021230650-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2021-11-18 — — WO disclosed
US-20190229271-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT DUK SAN NEOLUX CO., LTD. (KR) 2019-07-25 — — US disclosed
WO-2018012780-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRIC ELEMENT 덕산네오룩스 주식회사 2018-01-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240141-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF ESR1, GPX1, LEF1 MEN1 652/4885KMT2A 1921/4885MAPT 1456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.